Gudrun Hilgard
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, Immunotherapy and Immune Responses, HIV Research and Treatment
Most-Cited Works
- → Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial(2023)69 cited
- → GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients(2021)53 cited
- → Adaptation of the hepatitis B virus core protein to CD8+ T‐cell selection pressure(2015)51 cited
- → Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States(2024)29 cited
- → Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study(2022)19 cited
- → Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable(2015)18 cited
- → Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients(2021)17 cited
- → Clinical patterns associated with the concurrent detection of anti‐HBs and HBV DNA(2017)6 cited
- → Transient Interferon-Driven Natural Killer Cell Activation in Acute Hepatitis C(2025)1 cited
- → Long-term course of a patient with overlap hepatitis C and IgG4-related cholangitis(2020)